AK

Awadhesh Kumar

Active Director Additional Director DIN 08368157
DIN 08368157 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Past companies 1 historical roles
Total affiliations 8 Since Dec 2020
Shareholding value •••• Premium profile

About Awadhesh Kumar

Data last updated:

Awadhesh Kumar is an Additional Director at Edifice Life Sciences Private Limited (since 2023), Director at Membrane Pharma India Private Limited (since 2022) and Director at Edishark Ventures Private Limited (since 2026), and holds 4 more current directorships. The companies operate in Pharma, Trading and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹7.22 Cr; the largest is Edifice Life Sciences Private Limited at ₹6.55 Cr (FY 2025). Earlier, Awadhesh Kumar was a Director at Aaeris Lifecare Private Limited (2020–2021).

DIN 08368157
Primary Designation Additional Director
Industry Pharma
First Appointment 01 Dec 2020
Oldest Company Age 7 yrs
Largest company Edifice Life Sciences Private Limited · ₹6.55 Cr (FY 2025)
Combined revenue ₹7.22 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director22 Dec 20232019₹6.55 Cr (FY 2025)Active
Director26 May 20222021₹66.3 Lakh (FY 2025)Active
Edishark Ventures Private Limited U68100HR2026PTC150143
Director07 Sep 20262026Active
Designated Partner09 Jul 20242024Active
Partner15 Feb 20242024Active
D'latitude Pharmacy Private Limited U51909HR2022PTC103822
Director21 Jul 20222022Active
Director30 Aug 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aaeris Lifecare Private Limited U24290DL2019PTC352368
Director01 Dec 20202019₹70.8 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
D'latitude Pharmacy Private Limited
Prisma Vision Venture Partners Private Limited
Membrane Pharma India Private Limited
Medinence Solutions Llp
Premium access

Shareholding and investment profile for Awadhesh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Awadhesh Kumar

Awadhesh Kumar currently holds 7 directorships: Edifice Life Sciences Private Limited (Additional Director, since 22 Dec 2023, revenue ₹6.55 Cr (FY 2025)); Membrane Pharma India Private Limited (Director, since 26 May 2022, revenue ₹66.3 Lakh (FY 2025)); Edishark Ventures Private Limited (Director, since 07 Sep 2026); Medinence Solutions Llp (Designated Partner, since 09 Jul 2024); Edifice Biotech Llp (Partner, since 15 Feb 2024); and 2 more.

Awadhesh Kumar was first appointed on 01 Dec 2020 as Director at Aaeris Lifecare Private Limited. The most recent appointment on record is 07 Sep 2026 at Edishark Ventures Private Limited.

The 2 current companies of Awadhesh Kumar that report revenue have a combined latest revenue of ₹7.22 Cr: Edifice Life Sciences Private Limited ₹6.55 Cr (FY 2025); Membrane Pharma India Private Limited ₹66.3 Lakh (FY 2025).

Awadhesh Kumar held 1 earlier board appointment: Aaeris Lifecare Private Limited (Director, 01 Dec 2020 to 22 Mar 2021).

The current boards of Awadhesh Kumar's companies include Vikas (Edifice Life Sciences Private Limited), Heena Sardana (Membrane Pharma India Private Limited), Gourav Sardana (Edishark Ventures Private Limited), Deepa Gandhi (Medinence Solutions Llp), Sanjay Kumar Vaidya (Edifice Biotech Llp), Ramneet Kaur (Prisma Vision Venture Partners Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available